SCHEMBL24337097

SCHEMBL24337097

O=C1CCCC2=C1C(c1ccc(O)cc1)C1=C(CCCC1=O)O2

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.67
ALOX15 P16050 1/20 0.67
RECQL P46063 1/20 0.67
HTT P42858 2/20 0.56
CASP1 P29466 1/20 0.56
CASP7 P55210 1/20 0.56
CYP2C9 P11712 3/20 0.54
CYP2C19 P33261 3/20 0.54
CYP3A4 P08684 2/20 0.54
CYP2D6 P10635 2/20 0.54
NPSR1 Q6W5P4 2/20 0.54
GAA P10253 2/20 0.49
KDM4E B2RXH2 3/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.47
POLB P06746 1/20 0.46
MAPT P10636 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GLA P06280 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28161462 0.80 ALDH1A1 (0.45) ALDH1A1ALOX15RECQLHTTCASP1
SCHEMBL325499 0.77 GPR174 (0.57) ALDH1A1ALOX15RECQLHTTCYP2C9
SCHEMBL15450456 0.75 ALDH1A1 (0.52) ALDH1A1ALOX15RECQLHTTCASP1
SCHEMBL10046483 0.74 KMT2A (0.76) ALDH1A1ALOX15HTTNPSR1GAA
SCHEMBL11823279 0.73 ESR2 (0.50) ALDH1A1HTTCASP1CASP7CYP2C9
SCHEMBL15450451 0.70 GPR174 (0.55) ALDH1A1ALOX15RECQLHTTCYP2C9
SCHEMBL15450513 0.69 GPR174 (0.58) ALDH1A1ALOX15RECQLHTTCYP2C9
SCHEMBL8084149 0.69 GAA (0.67) ALDH1A1ALOX15RECQLHTTCYP2C9
SCHEMBL31238216 0.68 ALDH1A1 (0.53) ALDH1A1ALOX15RECQLCYP2C9CYP2C19
SCHEMBL13228482 0.67 GAA (0.64) ALDH1A1ALOX15RECQLHTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220110942-A1 GERM CELL NUCLEAR FACTOR LIGANDS AND METHODS OF USE THEREOF SAINT LOUIS UNIVERSITY (US) 2022-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220110942-A1 GERM CELL NUCLEAR FACTOR LIGANDS AND METHODS OF USE THEREOF NASP, ALPG, GMFG ALDH1A1 2726/4885ALOX15 3005/4885RECQL 3708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.